{"url":"https://lda.senate.gov/api/v1/filings/a2d2e18b-a476-4bc7-98dc-e572445b74c9/","filing_uuid":"a2d2e18b-a476-4bc7-98dc-e572445b74c9","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2018,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/a2d2e18b-a476-4bc7-98dc-e572445b74c9/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Crossley Marrow","dt_posted":"2019-01-18T10:25:43.493000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"555 12th Street, NW","registrant_address_2":"Suite 700","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401054971,"url":"https://lda.senate.gov/api/v1/registrants/401054971/","house_registrant_id":null,"name":"FTI GOVERNMENT AFFAIRS","description":"Consulting, Lobbying and Government Affairs","address_1":"555 12th Street NW","address_2":"Suite 700","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KEVIN BANASIK","contact_telephone":"+1 708-549-9120","dt_updated":"2026-07-29T09:09:26.182739-04:00"},"client":{"id":197420,"url":"https://lda.senate.gov/api/v1/clients/197420/","client_id":253,"name":"PERRIGO, INC.","general_description":"Develop, manufacture, and distribute packaging of OTC & prescription pharmaceuticals.","client_government_entity":false,"client_self_select":false,"state":"MI","state_display":"Michigan","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-03-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Dextromethorphan, Pseudoephedrine restriction issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58235,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"CRAWFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58233,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"PATRICK","last_name":"ROBERTSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicines. FDA's proposed changes to generic drug labeling. \"Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018\", H.R. 5333. \"Over-the-Counter Drug Safety, Innovation, and Reform Act\", S. 2315.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58235,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"CRAWFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58233,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"PATRICK","last_name":"ROBERTSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58257,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"STYLES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Monitor issues as they relate to the implementation of tax reform.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58235,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"CRAWFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58233,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"PATRICK","last_name":"ROBERTSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58257,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"STYLES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65072,"prefix":null,"prefix_display":null,"first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"CORMNEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}